We found no differences in secretoneurin serum concentrations between preterm infants with and without an imaging-based diagnosis of brain injury, but secretoneurin concentrations to a certain extent predicted neurodevelopmental outcome at 2 years of age. This evidence concerns the gene SCG2 and brain injury.